Your browser doesn't support javascript.
loading
Phase I study of escalating doses of carfilzomib with HyperCVAD in patients with newly diagnosed acute lymphoblastic leukemia.
Jonas, Brian A; Fisch, Samantha C; Rosenberg, Aaron S; Hoeg, Rasmus T; Tuscano, Joseph M; Abedi, Mehrdad.
  • Jonas BA; University of California, Davis School of Medicine, Sacramento, California, USA.
  • Fisch SC; University of California Davis Comprehensive Cancer Center, Sacramento, California, USA.
  • Rosenberg AS; Veterans Administration Northern California Health Care System, Mather, California, USA.
  • Hoeg RT; University of California, Davis School of Medicine, Sacramento, California, USA.
  • Tuscano JM; University of California, Davis School of Medicine, Sacramento, California, USA.
  • Abedi M; University of California Davis Comprehensive Cancer Center, Sacramento, California, USA.
Am J Hematol ; 96(4): E114-E117, 2021 04 01.
Article en En | MEDLINE | ID: mdl-33476436
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Diagnostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Diagnostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article